Is RAD51 135G>C polymorphism really associated with breast cancer in general population? Biased design and results lead to inappropriate conclusion

Author： Yu Ke-Da Li Bin Zhou Ying Shao Zhi-Ming

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.128, Iss.1, 2011-07, pp. : 297-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis

By Zhou Guo-Wu

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 529-535

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects

By Wang Zhanwei Dong Hairong Fu Yuanyuan Ding Haixia

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 765-769

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies

By Gao Lin-Bo

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 827-835

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies

By Yu Ke-Da

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 365-371

Springer Publishing Company

Access to resources Recommend Favorite

RAD51C germline mutations in Chinese women with familial breast cancer

By Pang Zhiyuan

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 1019-1020

Springer Publishing Company

Access to resources Recommend Favorite